Literature DB >> 33852230

Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.

Emily Breidbart1, Liyong Deng2, Patricia Lanzano2, Xiao Fan2, Jiancheng Guo2, Rudolph L Leibel2, Charles A LeDuc2, Wendy K Chung2.   

Abstract

OBJECTIVES: There have been few large-scale studies utilizing exome sequencing for genetically undiagnosed maturity onset diabetes of the young (MODY), a monogenic form of diabetes that is under-recognized. We describe a cohort of 160 individuals with suspected monogenic diabetes who were genetically assessed for mutations in genes known to cause MODY.
METHODS: We used a tiered testing approach focusing initially on GCK and HNF1A and then expanding to exome sequencing for those individuals without identified mutations in GCK or HNF1A. The average age of onset of hyperglycemia or diabetes diagnosis was 19 years (median 14 years) with an average HbA1C of 7.1%.
RESULTS: Sixty (37.5%) probands had heterozygous likely pathogenic/pathogenic variants in one of the MODY genes, 90% of which were in GCK or HNF1A. Less frequently, mutations were identified in PDX1, HNF4A, HNF1B, and KCNJ11. For those probands with available family members, 100% of the variants segregated with diabetes in the family. Cascade genetic testing in families identified 75 additional family members with a familial MODY mutation.
CONCLUSIONS: Our study is one of the largest and most ethnically diverse studies using exome sequencing to assess MODY genes. Tiered testing is an effective strategy to genetically diagnose atypical diabetes, and familial cascade genetic testing identified on average one additional family member with monogenic diabetes for each mutation identified in a proband.
© 2021 Walter de Gruyter GmbH, Berlin/Boston.

Entities:  

Keywords:  MODY; diabetes; genetics in diabetes and obesity; molecular genetics

Mesh:

Substances:

Year:  2021        PMID: 33852230      PMCID: PMC8970616          DOI: 10.1515/jpem-2020-0501

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  37 in total

1.  beta-cell genes and diabetes: molecular and clinical characterization of mutations in transcription factors.

Authors:  T M Frayling; J C Evans; M P Bulman; E Pearson; L Allen; K Owen; C Bingham; M Hannemann; M Shepherd; S Ellard; A T Hattersley
Journal:  Diabetes       Date:  2001-02       Impact factor: 9.461

2.  Clinical whole exome sequencing in early onset diabetes patients.

Authors:  Soo Heon Kwak; Chan-Hyeon Jung; Chang Ho Ahn; Jungsun Park; Jeesoo Chae; Hye Seung Jung; Young Min Cho; Dae Ho Lee; Jong-Il Kim; Kyong Soo Park
Journal:  Diabetes Res Clin Pract       Date:  2016-10-15       Impact factor: 5.602

3.  ISPAD Clinical Practice Consensus Guidelines 2018: The diagnosis and management of monogenic diabetes in children and adolescents.

Authors:  Andrew T Hattersley; Siri A W Greeley; Michel Polak; Oscar Rubio-Cabezas; Pål R Njølstad; Wojciech Mlynarski; Luis Castano; Annelie Carlsson; Klemens Raile; Dung V Chi; Sian Ellard; Maria E Craig
Journal:  Pediatr Diabetes       Date:  2018-10       Impact factor: 4.866

4.  Early-onset Type II diabetes mellitus in Italian families due to mutations in the genes encoding hepatic nuclear factor 1 alpha and glucokinase.

Authors:  C Gragnoli; B N Cockburn; F Chiaramonte; A Gorini; G Marietti; G Marozzi; A M Signorini
Journal:  Diabetologia       Date:  2001-10       Impact factor: 10.122

5.  Mutations in GCK and HNF-1alpha explain the majority of cases with clinical diagnosis of MODY in Spain.

Authors:  Itziar Estalella; Itxaso Rica; Guiomar Perez de Nanclares; Jose Ramon Bilbao; Jose Antonio Vazquez; Jose Ignacio San Pedro; Maria Angeles Busturia; Luis Castaño
Journal:  Clin Endocrinol (Oxf)       Date:  2007-06-15       Impact factor: 3.478

Review 6.  Maturity onset diabetes of the young: clinical characteristics, diagnosis and management.

Authors:  Fotini K Kavvoura; Katharine R Owen
Journal:  Pediatr Endocrinol Rev       Date:  2012 Dec-2013 Jan

7.  Phenotypical aspects of maturity-onset diabetes of the young (MODY diabetes) in comparison with Type 2 diabetes mellitus (T2DM) in children and adolescents: experience from a large multicentre database.

Authors:  E Schober; B Rami; M Grabert; A Thon; Th Kapellen; Th Reinehr; R W Holl
Journal:  Diabet Med       Date:  2009-05       Impact factor: 4.359

Review 8.  MODY: history, genetics, pathophysiology, and clinical decision making.

Authors:  Stefan S Fajans; Graeme I Bell
Journal:  Diabetes Care       Date:  2011-08       Impact factor: 19.112

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease.

Authors:  Na Zhu; Carrie L Welch; Jiayao Wang; Philip M Allen; Claudia Gonzaga-Jauregui; Lijiang Ma; Alejandra K King; Usha Krishnan; Erika B Rosenzweig; D Dunbar Ivy; Eric D Austin; Rizwan Hamid; Michael W Pauciulo; Katie A Lutz; William C Nichols; Jeffrey G Reid; John D Overton; Aris Baras; Frederick E Dewey; Yufeng Shen; Wendy K Chung
Journal:  Genome Med       Date:  2018-07-20       Impact factor: 11.117

View more
  1 in total

1.  Maturity-onset diabetes of the young in a large Portuguese cohort.

Authors:  Sílvia Santos Monteiro; Tiago da Silva Santos; Liliana Fonseca; Guilherme Assunção; Ana M Lopes; Diana B Duarte; Ana Rita Soares; Francisco Laranjeira; Isaura Ribeiro; Eugénia Pinto; Sónia Rocha; Sofia Barbosa Gouveia; María Eugenia Vazquez-Mosquera; Maria João Oliveira; Teresa Borges; Maria Helena Cardoso
Journal:  Acta Diabetol       Date:  2022-10-08       Impact factor: 4.087

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.